(Integration and Validation of Emerging Technologies to Accelerate Cancer Research (R33

The purpose of this FOA is to promote research on the advanced development and rigorous validation of new enabling technologies/tools/capabilities with a transformative potential for cancer research and clinical oncology. Specifically, this FOA targets the following four areas designated as scientific priorities:

• Enhanced experimental and analytical capabilities addressing complexities of cancer development;
• New capabilities advancing precise clinical diagnosis of cancer patients;
• Novel predictive ex vivo and/or in silico modeling approaches; and
• New technologies/approaches to improve biospecimen and data quality.

Funding: $325,000

Duration: 3 years

LOI due date: 10.4.17

Research Authority deadline: 3.5..17

Full application due dates: 10.5.17